You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨智飛生物(300122.SZ)4日連漲近20% 去年淨利大增兩倍破百億
格隆匯 02-10 14:41
格隆匯2月10日丨智飛生物(300122.SZ)續升超4%,4日連漲近20%。現報124.5元,暫成交21.35億元,總市值1994億元。公司2021年實現營業收入約306.37億元,同比增加101.68%;淨利潤約101.97億元,同比增加208.88%。期內公司加大研發投入推陳出新,自主產品與代理產品銷售均持續穩步提升。方正證券研報指出,去年上半年,智飛生物研發新冠疫苗的子公司安徽智飛龍科馬生物製藥有限公司收入達53.13億元,因此,市場推測“其增長收入即為新冠疫苗收入”。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account